This site is intended only for UK patients who have been prescribed Fasenra (benralizumab) for Severe Eosinophilic Asthma, or their caregiver

The Patient Information Leaflet for Fasenra is available here

This site is intended only for UK patients who have been prescribed Fasenra (benralizumab) for Severe Eosinophilic Asthma, or their caregiver

The Patient Information Leaflet for Fasenra is available here

  • Home
  • Learn more about FASENRA®
  • Help with self-administration
  • Helpful resources
  • Home
  • Learn more about FASENRA®
  • Help with self-administration
  • Helpful resources

HELP WITH SELF-ADMINISTRATION

HELP WITH
SELF-ADMINISTRATION

This section provides information for you to learn how to use your Fasenra® pre-filled pen.

Fasenra® can be injected either in a hospital outpatient clinic or, after training, by you or a caregiver. Your doctor will be able to advise what is more suitable for you.

If your doctor has recommended that you or a caregiver administer your Fasenra® injection:

It's normal to feel nervous about giving yourself an injection. Once you learn how to administer your new medication, you may find it's much easier than you think. You can watch a video guide on how to use your Fasenra pre-filled pen, or download the instructions for use.

FASENRA®

PRE-FILLED PEN

FASENRA® PRE-FILLED PEN

Step by step instructions

Download

It is recommended that you remove Fasenra® from the fridge 30 minutes before administration to allow it to warm up to room temperature.

Learn more about eosinophilic asthma and Fasenra®

GB-70341 I September 2025

Fasenra® (benralizumab) Connect 360, an AstraZeneca UK developed and funded website

The content on this website is intended only for UK patients who have been prescribed Fasenra (benralizumab) for Severe Eosinophilic Asthma, or their caregiver

I am not a UK patient who has been prescribed Fasenra, or their caregiver
  • Legal notice and terms of use
  • |
  • Contact Us
  • |
  • Privacy Policy
  • |
  • Cookie Notice

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects, you can help provide more information on the safety of this medicine.

This is a non-promotional website developed and funded by AstraZeneca.

 

This site is intended to complement, not replace the 'Instructions for Use' and 'Patient Information Leaflet' (found in your medicine pack). Refer to these materials for additional important information.

 

If you have any questions or concerns about your treatment, you should always talk to your healthcare team.

 

FASENRA® is a registered trademark of the AstraZeneca group of companies. ©2025 AstraZeneca All rights reserved. GB-70406 I September 2025